A new family of neurotransmitter transporters: the high-affinity glutamate transporters. 1993

Y Kanai, and C P Smith, and M A Hediger
Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.

An essential component of the transmission process at glutamatergic synapses is the removal of glutamate from the synaptic cleft. This is achieved by powerful transport systems which have a high affinity for glutamate and exhibit a novel coupling to inorganic ions. Transporters situated on presynaptic termini sequester glutamate directly from the synaptic cleft. In concert, transporters situated on glial cells maintain a low extracellular glutamate concentration, thereby establishing a diffusion gradient favoring movement of glutamate out of the synaptic cleft. Maintenance of a low extracellular glutamate concentration also serves to protect neurons from the excitotoxic action of glutamate. Despite the physiological importance of the glutamate transporters, little information has been available on their molecular structures. This gap, however, has begun to be bridged with the recent cloning of three species of eukaryotic glutamate transporters. The purpose of this review is to summarize the results of these three cloning successes, to compare and contrast the three novel transporters, and to reinterpret, in the light of these recent breakthroughs, information from previous studies.

UI MeSH Term Description Entries
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D002352 Carrier Proteins Proteins that bind or transport specific substances in the blood, within the cell, or across cell membranes. Binding Proteins,Carrier Protein,Transport Protein,Transport Proteins,Binding Protein,Protein, Carrier,Proteins, Carrier
D002493 Central Nervous System Diseases Diseases of any component of the brain (including the cerebral hemispheres, diencephalon, brain stem, and cerebellum) or the spinal cord. CNS Disease,Central Nervous System Disease,Central Nervous System Disorder,CNS Diseases,Central Nervous System Disorders
D006023 Glycoproteins Conjugated protein-carbohydrate compounds including MUCINS; mucoid, and AMYLOID glycoproteins. C-Glycosylated Proteins,Glycosylated Protein,Glycosylated Proteins,N-Glycosylated Proteins,O-Glycosylated Proteins,Glycoprotein,Neoglycoproteins,Protein, Glycosylated,Proteins, C-Glycosylated,Proteins, Glycosylated,Proteins, N-Glycosylated,Proteins, O-Glycosylated
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D017470 Receptors, Glutamate Cell-surface proteins that bind glutamate and trigger changes which influence the behavior of cells. Glutamate receptors include ionotropic receptors (AMPA, kainate, and N-methyl-D-aspartate receptors), which directly control ion channels, and metabotropic receptors which act through second messenger systems. Glutamate receptors are the most common mediators of fast excitatory synaptic transmission in the central nervous system. They have also been implicated in the mechanisms of memory and of many diseases. Excitatory Amino Acid Receptors,Glutamate Receptors,Receptors, Excitatory Amino Acid,Excitatory Amino Acid Receptor,Glutamate Receptor,Receptor, Glutamate
D018377 Neurotransmitter Agents Substances used for their pharmacological actions on any aspect of neurotransmitter systems. Neurotransmitter agents include agonists, antagonists, degradation inhibitors, uptake inhibitors, depleters, precursors, and modulators of receptor function. Nerve Transmitter Substance,Neurohormone,Neurohumor,Neurotransmitter Agent,Nerve Transmitter Substances,Neurohormones,Neurohumors,Neuromodulator,Neuromodulators,Neuroregulator,Neuroregulators,Neurotransmitter,Neurotransmitters,Substances, Nerve Transmitter,Transmitter Substances, Nerve,Substance, Nerve Transmitter,Transmitter Substance, Nerve
D027322 Amino Acid Transport System X-AG A family of POTASSIUM and SODIUM-dependent acidic amino acid transporters that demonstrate a high affinity for GLUTAMIC ACID and ASPARTIC ACID. Several variants of this system are found in neuronal tissue. Glutamate-Aspartate Transporter,Amino Acid Transport System XAG,GLAST Glutamate-Aspartate Transporters,Glutamate Translocase,Glutamate Transport Glycoprotein,Glutamate Transporter,Amino Acid Transport System X AG,GLAST Glutamate Aspartate Transporters,Glutamate Aspartate Transporter,Glutamate-Aspartate Transporters, GLAST,Transport Glycoprotein, Glutamate,Transporter, Glutamate-Aspartate,Transporters, GLAST Glutamate-Aspartate

Related Publications

Y Kanai, and C P Smith, and M A Hediger
October 2000, Sheng li ke xue jin zhan [Progress in physiology],
Y Kanai, and C P Smith, and M A Hediger
June 1993, FEBS letters,
Y Kanai, and C P Smith, and M A Hediger
July 1992, Trends in neurosciences,
Y Kanai, and C P Smith, and M A Hediger
September 2017, Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences,
Y Kanai, and C P Smith, and M A Hediger
July 1997, Molecular pharmacology,
Y Kanai, and C P Smith, and M A Hediger
July 1992, Proceedings of the National Academy of Sciences of the United States of America,
Y Kanai, and C P Smith, and M A Hediger
January 1998, Brain research bulletin,
Y Kanai, and C P Smith, and M A Hediger
November 1998, Journal of neurochemistry,
Y Kanai, and C P Smith, and M A Hediger
January 1999, Advances in experimental medicine and biology,
Y Kanai, and C P Smith, and M A Hediger
February 2000, The Plant cell,
Copied contents to your clipboard!